SEO URLwww.firestrike.ai/deals/takeda-pharmaceutical-company-takeda-pharmaceutical-company-acquisition-2026
acquisitionAnnounced · Jan 18, 2026PharmaceuticalsSource · MagazinesArticle · Factual
Takeda Pharmaceutical Company acquires Takeda Pharmaceutical Company
David Najork · Founding Software Engineer
Announced · Updated · 1 min read
Deal value
$63.1B
Target
Takeda Pharmaceutical Company
NYSE: TAK · Tokyo, Tokyo
Acquirer
Takeda Pharmaceutical Company
Full Acquisition
Status
Completed
Takeda Pharmaceutical Company agreed to acquire Takeda Pharmaceutical Company. Reported deal value: $63.1B. Status: Completed. Sector: Pharmaceuticals. Target headquarters context: Tokyo, Tokyo, Japan.
This page summarizes publicly available information about the transaction as of 2026-01-18. Figures and status may change as filings and press coverage update.
Takeda pharmaceutical gamble pays off spectacularly Takeda Pharmaceuticals ’ $63.1 billion acquisition of Shire in 2019 delivered the fastest revenue expansion among all major corporate purchases analyzed
Deal timeline
Announced
Jan 18, 2026 · rollingout.com
Additional milestones (proxy, vote, close) appear as filings and press updates are indexed.
Sector context
This transaction is classified in Pharmaceuticals with a reported deal value of $63.1B. Figures and status may change as sources update.
Sources: rollingout.com · Primary article · FireStrike proprietary index